Ocular Therapeutix (OCUL) Non-Current Deffered Revenue (2020 - 2026)
Ocular Therapeutix's Non-Current Deffered Revenue was $14 million in Q2 2026, unchanged from $14 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Non-Current Deffered Revenue (2020 - 2026) Analysis & Trends
From Q4 2020 onward, Ocular Therapeutix has reported Non-Current Deffered Revenue for 23 quarters.
- Non-Current Deffered Revenue shows a five-year compound annual growth rate of 3.1% (FY2020 to FY2025).
- In earlier years, Non-Current Deffered Revenue was $14 million in FY2024 (-1.0%), $14.14 million in FY2023 (+5.6%), $13.39 million in FY2022 (+3.0%) and $13 million in FY2021 (+8.3%).
- Quarterly Non-Current Deffered Revenue has moved between $12 million (Q3 2021) and $14.25 million (Q2 2023) over five years.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q3 2022 (growth of 12.8%); the worst was Q2 2024 (a decline of 1.8%).
- Per Business Quant data, OCUL's Non-Current Deffered Revenue in the three quarters before Q2 2026 was $14 million (Q1 2026), $14 million (Q4 2025) and $14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | - |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 14.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 14.00 Mn |
| Sep 30, 2025 | 14.00 Mn |
| Jun 30, 2025 | 14.00 Mn |
| Mar 31, 2025 | 14.00 Mn |
| Dec 31, 2024 | 14.00 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.07 Mn |
| Dec 31, 2023 | 14.14 Mn |
| Sep 30, 2023 | 14.20 Mn |
| Jun 30, 2023 | 14.25 Mn |
| Mar 31, 2023 | 13.34 Mn |
| Dec 31, 2022 | 13.39 Mn |
| Sep 30, 2022 | 13.53 Mn |
| Jun 30, 2022 | 13.00 Mn |
| Mar 31, 2022 | 13.10 Mn |
| Dec 31, 2021 | 13.00 Mn |
| Sep 30, 2021 | 12.00 Mn |
API Access
Ocular Therapeutix Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();